PTGS2 and rheumatic disorder: Moreover, all the above stated compounds can be future therapeutic alternative for treating inflammation associated diseases including neurodegenerative diseases, rheumatisms, and various cancers, where excessive COX-2 activity and PGE2 production plays significant role in development and progression.